← All Sponsors
SPONSOR

Newave Pharmaceutical Inc

Total Trials
1
Recruiting
1
Phases
Phase 1
Conditions studied: CLL/SLLWaldenstrom MacroglobulinemiaFollicular LymphomaDiffuse Large B Cell LymphomaMantle Cell LymphomaMarginal Zone LymphomaHairy Cell Leukemia
NCT04775745 Phase 1
Recruiting

Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.

CLL/SLL
United States View Trial →